Cefazolin should be administered maximum 30 min before incision in total knee arthroplasty when tourniquet is used

Area of Science:

• Orthopedic Surgery
• Infectious Disease
• Pharmacology

Background:

• Periprosthetic joint infection is a significant complication of total knee arthroplasty (TKA), occurring in 0.4-2% of patients.
• Staphylococcus aureus and Staphylococcus epidermidis are the most common pathogens responsible for over half of these infections.
• Cefazolin is the standard antibiotic prophylaxis for arthroplasty worldwide.

Purpose of the Study:

• To determine the optimal timing for cefazolin administration before TKA to maximize antibiotic bone and serum concentrations.
• To propose a new cefazolin administration protocol based on its pharmacokinetic profile.

Main Methods:

• Analysis of cefazolin pharmacokinetics, including serum half-life (108 min) and bone half-life (42 min).
• Utilizing a theoretical mathematical model to predict optimal drug concentration timing.
• Comparing current guidelines (infusion within 60 min pre-incision) with a proposed new timing.

Main Results:

• Cefazolin achieves peak bone concentrations 40 minutes after parenteral administration.
• The proposed optimal administration window is 10-30 minutes before tourniquet inflation (surgical incision).
• This timing aims for maximal blood and near-maximal bone cefazolin concentrations at the start of surgery.

Conclusions:

• Current guidelines for cefazolin prophylaxis timing may not be optimal.
• Administering cefazolin 10-30 minutes before tourniquet inflation is hypothesised to enhance its efficacy in preventing periprosthetic joint infections.
• Further clinical studies are warranted to validate this optimized prophylactic regimen.